What You Should Know:
– Sonde Health is expanding its leading health monitoring platform beyond mental and respiratory fitness by introducing an innovative cognitive fitness tracker that allows users to monitor brain exertion, or cognitive effort, in real time.
– This new solution, called Sonde Cognitive Fitness, analyzes eight vocal characteristics from 30-second voice interactions and generates a score to provide insight into one’s cognitive state, helping people manage their mental well-being and productivity effectively.
Sonde Health: Leading Voice-Based Cognitive Fitness Monitoring
Sonde Health stands at the forefront of voice-based health tracking and data insights, offering innovative solutions through its vocal biomarker API/SDK. Serving a range of enterprise applications from consumer wellness to population health, Sonde leverages a comprehensive voice dataset and clinical research, featuring over 1.2 million samples from more than 85,000 individuals across four continents. Using advanced audio signal processing, speech science, and AI/machine learning, Sonde detects subtle vocal changes that indicate shifts in an individual’s physiology, providing critical insights into health and well-being.
Sonde Cognitive Fitness enables individuals to monitor cognitive effort levels through a simple, passive 30-second voice sample collected via most smart devices. The tool measures vocal biomarkers to generate a cognitive effort score categorized as:
– Efficient (80-100): Low cognitive effort
– Balanced (70-79): Moderate cognitive effort
– Demanding (0-69): High cognitive effort
This capability allows users to optimize productivity, enhance performance, and reduce cognitive strain.
The launch of Sonde Cognitive Fitness comes at a crucial time, as nearly one in five people over the age of 50 worldwide experience mild cognitive impairment (MCI), and over 55 million people are living with dementia—a figure expected to nearly triple by 2050. Highlighting the importance of early intervention, the U.S. Food and Drug Administration (FDA) recently approved a second drug designed to slow the early stages of Alzheimer’s disease.
To develop Sonde Cognitive Fitness, Sonde Health collaborated with GN Group and clinical experts in cognitive impairment from esteemed institutions such as Massachusetts General Hospital and Montefiore Medical Center at the Albert Einstein College of Medicine. Research studies involved nearly 700 older adults, whose cognitive abilities were assessed using traditional tools like Addenbrooke’s Cognitive Examination (ACE), the Blessed Dementia Scale, and the Clinical Dementia Rating (CDR) scale. The cognitive fitness scores from Sonde showed strong alignment with these traditional assessments.
Sonde ensures privacy and security through a rigorous verification process, collecting voice samples only from enrolled and consented users, with no audio stored or transmitted off-device. Sonde Cognitive Fitness is designed for seamless integration via its API and SDK, facilitating easy adoption across various platforms and devices.
By tracking cognitive fitness, Sonde Health empowers individuals to maintain and enhance their cognitive well-being, offering a critical tool in the global effort to combat cognitive decline and support healthy aging.
